Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18498478 | 0.81 | ATM (0.38) | ATMAGTR2 | |
| SCHEMBL26115388 | 0.80 | ATM (0.37) | ATMAGTR2 | |
| SCHEMBL696186 | 0.79 | HSD17B10 (0.42) | ATM | |
| SCHEMBL23925765 | 0.79 | HSD17B10 (0.42) | ATM | |
| SCHEMBL23925766 | 0.79 | HSD17B10 (0.42) | ATM | |
| SCHEMBL3070231 | 0.76 | CTSS (0.42) | — | |
| SCHEMBL21806913 | 0.75 | POLB (0.31) | — | |
| SCHEMBL22029854 | 0.74 | ATM (0.44) | ATMAGTR2 | |
| SCHEMBL6276413 | 0.74 | ATM (0.44) | ATMAGTR2 | |
| SCHEMBL6270654 | 0.74 | ATM (0.44) | ATMAGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023183405-A2 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | ALEXION PHARMACEUTICALS, INC. (US) | 2023-09-28 | — | — | WO | disclosed |
| EP-4216946-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | Achillion Pharmaceuticals, Inc. (US) | 2023-08-02 | — | — | EP | disclosed |